SEC Form 4 · accession 0001209191-18-057640
Azenta, Inc. · AZTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Maurice H. Tenney
Officer — President-Brooks Life Sciences
Period of report
Nov 5, 2018
Accepted (ET)
Nov 7, 2018 · 5:18 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000933974
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 5, 2018 | S | 2,052 | $31.76 | D | 145,777 | D | |
| Common StockF2 | Nov 6, 2018 | A | 43,140 | $0.00 | A | 188,917 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sale of shares by the reporting person to satisfy the reporting person's obligations with respect to withholding taxes in connection with the vesting on November 4, 2018 of 6,668 restricted stock units held by the reporting person.
- F2An initial grant of 80,000 restricted stock units (RSUs) was received on November 4, 2015 and reported on Form 4 dated November 6, 2015. The grant contained 60,000 performance-based units subject to performance-based vesting requirements, measured at the three-year period ended September 30, 2018, resulting in the achievement of 171.9%, or 103,140 of the performance-based units. This transaction represents a grant of an additional 43,140 RSUs. No amount was paid upon grant of RSUs.